Buffi NM - Search Results

1

The Role of Tumor Volume Ratio in Predicting Clinically Significant Prostate Cancer on Transperineal Biopsy.

Avolio PP, Hassan T, Addar A, Alshamsi H, McPherson V, Buffi NM, Lughezzani G, Loutochin O, Rompré-Brodeur A, Anidjar M, Sanchez-Salas R. Avolio PP, et al. Among authors: buffi nm. J Endourol. 2024 Nov 26. doi: 10.1089/end.2024.0428.fts24. Online ahead of print. J Endourol. 2024. PMID: 39587895

2

Simplifying patient positioning and port placement during robotic-assisted laparoscopic prostatectomy.

Cestari A, Buffi NM, Scapaticci E, Lughezzani G, Salonia A, Briganti A, Rigatti P, Montorsi F, Guazzoni G. Cestari A, et al. Among authors: buffi nm. Eur Urol. 2010 Mar;57(3):530-3. doi: 10.1016/j.eururo.2009.11.028. Epub 2009 Nov 17. Eur Urol. 2010. PMID: 19963314

3

Oncologic results of laparoscopic renal cryoablation for clinical T1a tumors: 8 years of experience in a single institution.

Guazzoni G, Cestari A, Buffi N, Lughezzani G, Nava L, Cardone G, Balconi G, Lazzeri M, Montorsi F, Rigatti P. Guazzoni G, et al. Urology. 2010 Sep;76(3):624-9. doi: 10.1016/j.urology.2010.03.078. Epub 2010 Jun 25. Urology. 2010. PMID: 20579705

4

Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer.

Guazzoni G, Lazzeri M, Nava L, Lughezzani G, Larcher A, Scattoni V, Gadda GM, Bini V, Cestari A, Buffi NM, Freschi M, Rigatti P, Montorsi F. Guazzoni G, et al. Among authors: buffi nm. Eur Urol. 2012 Mar;61(3):455-66. doi: 10.1016/j.eururo.2011.10.038. Epub 2011 Nov 4. Eur Urol. 2012. PMID: 22078333

5

Feasibility and preliminary clinical outcomes of robotic laparoendoscopic single-site (R-LESS) pyeloplasty using a new single-port platform.

Cestari A, Buffi NM, Lista G, Lughezzani G, Larcher A, Lazzeri M, Sangalli M, Rigatti P, Guazzoni G. Cestari A, et al. Among authors: buffi nm. Eur Urol. 2012 Jul;62(1):175-9. doi: 10.1016/j.eururo.2012.03.041. Epub 2012 Mar 28. Eur Urol. 2012. PMID: 22469392

6

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F. Lughezzani G, et al. BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4. BJU Int. 2013. PMID: 22487441

7

Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.

Lazzeri M, Briganti A, Scattoni V, Lughezzani G, Larcher A, Gadda GM, Lista G, Cestari A, Buffi N, Bini V, Freschi M, Rigatti P, Montorsi F, Guazzoni G. Lazzeri M, et al. J Urol. 2012 Oct;188(4):1137-43. doi: 10.1016/j.juro.2012.06.017. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901578

8

Development and internal validation of a Prostate Health Index based nomogram for predicting prostate cancer at extended biopsy.

Lughezzani G, Lazzeri M, Larcher A, Lista G, Scattoni V, Cestari A, Buffi NM, Bini V, Guazzoni G. Lughezzani G, et al. Among authors: buffi nm. J Urol. 2012 Oct;188(4):1144-50. doi: 10.1016/j.juro.2012.06.025. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901589

9

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project.

Lazzeri M, Haese A, Abrate A, de la Taille A, Redorta JP, McNicholas T, Lughezzani G, Lista G, Larcher A, Bini V, Cestari A, Buffi N, Graefen M, Bosset O, Le Corvoisier P, Breda A, de la Torre P, Fowler L, Roux J, Guazzoni G. Lazzeri M, et al. BJU Int. 2013 Aug;112(3):313-21. doi: 10.1111/bju.12217. BJU Int. 2013. PMID: 23826841

10

Relationship of chronic histologic prostatic inflammation in biopsy specimens with serum isoform [-2]proPSA (p2PSA), %p2PSA, and prostate health index in men with a total prostate-specific antigen of 4-10 ng/ml and normal digital rectal examination.

Lazzeri M, Abrate A, Lughezzani G, Gadda GM, Freschi M, Mistretta F, Lista G, Fossati N, Larcher A, Kinzikeeva E, Buffi N, Dell'Acqua V, Bini V, Montorsi F, Guazzoni G. Lazzeri M, et al. Urology. 2014 Mar;83(3):606-12. doi: 10.1016/j.urology.2013.10.016. Epub 2013 Dec 6. Urology. 2014. PMID: 24315305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters